Introduction
Canadian study compared the patient survival of 284 transplant recipients above age 60 years with that of At the threshold of the millenium the industrial counthe sex-and age-matched general population. The tries have to face the problem of an increasingly aged survival at 5 years was 75 and 88% respectively [6 ] . A population. Between 1900 and 1980 the life expectancy careful selection of the recipient, paying particular per person at age 65 has risen from 11.9 years to 16.4 attention to potential evidence of cardiovascular disyears. During the 1980s the number of people aged ease, could further reduce the risk. 75-79 increased by 28.8% and that of persons over the Even more encouraging are the data about graft age of 85 years by 52.4% [1] . It should be pointed out
survival. An analysis of UNOS showed that the 5-year that not only has the life expectancy of older persons graft survival was similar in transplant recipients above improved, but also their general health status is subage 60 years and in those aged 0-60 years. Graft stantially better than in the past. The longevity revolusurvival declined in older patients after the 5th year tion will continue to increase in the future and will because of their high rate of death. However, the represent a major problem for politicians, economists, so-called functional graft survival, excluding death, and sociologists.
was better for patients above age 60 years than for If the number of elderly persons in the general any other age group, mainly because of the lower population is progressively increasing, the number of number of grafts lost by rejection in the elderly group elderly uraemic patients requiring renal replacement [5] . Two factors may account for the low incidence of therapy has increased even more rapidly in recent rejection in elderly patients: (i) elderly patients are years, creating a true 'elderly boom' in dialysis units.
usually more compliant than younger transplant recipiThe number of dialysis patients older than 65 years has more than doubled within 10 years in the US [2] . ents [7] ; (ii) in the elderly the inflammatory and In Europe, more than 50% of new patients admitted immune responses are blunted. Particularly, producto dialysis in 1995 were older than 60 years; in Italy tion of IL-2, expression of IL-2 receptors, cellular and and in France, 35% of dialysis patients were older than immunological responses, and expression of HLA-DR 70 years [3] .
antigens are attenuated [8] . Although many elderly patients on dialysis are frail Probably the most convincing data about the feasib- [4] , a consistent number of older patients are well ility of renal transplantation in the elderly are those rehabilitated and do not have comorbid conditions produced recently by the group of Rotterdam. that would be a contraindication to transplantation. Roodnat et al. [9] subdivided their population of Yet many centres are still reluctant to accept patients cyclosporin-treated cadaver renal graft recipients into older than 60-65 years as candidates for renal trans-three comparably sized age groups (17-43 years, 44-55 plantation. Two main objections for transplanting years, and 56-75 years). Patients were transplanted older patients are generally advanced: (i) patient and between 1983 and 1997. Three time periods were graft survival is poor in the elderly; (ii) life-expectancy considered. In each of them the relative risk of graft for elderly patients is better on dialysis than with a failure, including death, remained stable. Assuming transplant.
that the relative risk of graft failure was 1.0 in the period between 1983 and 1990, it decreased subsequently and was 0.49 in the period 1991-1993 and
Patient and graft survival in older recipients
0.22 between 1994 and 1997. In each of these periods the older the age of the As expected, in renal transplant recipients as well as recipients the higher the risk of graft failure, but the in general population the more advanced the age the impact of age was considerably attenuated between shorter the life expectancy [5] . However, the difference the first and the third period. Because of the improving in survival between older transplant patients and the results, the risk of graft failure or death was similar for a 20-year-old recipient transplanted between 1983 Correspondence and offprint requests to: C. Ponticelli, Divisione di and 1990 and for a 70-year-old recipient transplanted 
On the basis of the available data, one may conclude in elderly patients are represented by cardiovascular diseases and infections. However, colonic perforation that, thanks to the improving results of transplantation, the impact of the recipient's age on the results of [12], gastric haemorrhage, and acute cholecystitis [8] are also frequent causes of mortality. Cardiac risk may transplantation has been considerably reduced and that today age per se no longer constitutes a contrain-be evaluated by thallium scintigraphy and/or dobutamine echocardiography, but some investigators advocdication to transplantation. ated routine coronary angiography, particularly in diabetic patients. Coronary revascularization may
Patient survival with dialysis or transplantation in
reduce the post-transplantation cardiovascular events the elderly and the silent cardiac infarcts which represent a frequent cause of death in the elderly [13] . An accurate search and correction of infections is also needed. A In the pre-cyclosporin era there were conflicting opinpre-emptive treatment with ganciclovir can reduce the ions on whether dialysis should be preferred to renal risk of cytomegalovirus (CMV ) infections, which may transplantation in older patients or vice versa. Most expose the patient to opportunistic, life-threatening studies found no relevant difference in survival between infections. Antiviral therapy is mandatory for seronegelderly patients on regular dialysis and patients who ative recipients receiving seropositive CMV transunderwent renal transplantation [8] . The results of plants. Colonic perforation most often results from kidney allograft have improved after the introduction diverticulitis. Therefore, barium enema or colonoscopy of cyclosporin and amelioration of supportive therapshould be part of the pretransplant evaluation. What ies. Recently, the US Renal Data System showed that to do in the presence of diverticular disease in a in patients over 65 years renal transplantation reduced transplant candidate is still uncertain. Some centres the risk of death more than threefold when compared perform hemicolectomy, particularly in the case of with dialysis. These data could be biased, however, by symptomatic diverticulitis; others recommend intestcase selection [8] .
inal disinfection and prevention of constipation. More reliable are the results of those studies that However, it is important to suspect colonic perforation compared the survival of older dialysis patients selected in the presence of abdominal pain and unexplained for transplantation who did not receive a renal allograft fever. Gall-bladder ultrasound should be performed with the survival of patients of the same age who were before transplantation in order to eliminate transplanted and received a cyclosporin-based regimen cholelithiasis. [6, 10, 11] . After correction for comorbid factors, all
(ii) A possible advantage of renal transplantation in the studies found a striking difference in patient surolder recipients is their blunted inflammatory and vival in favour of transplant recipients. In a Canadian immune response and lower incidence of rejection study, the 5-year survival for patients older than 60 [5, 12, 14] . This may allow the reduction of the intensity years was 80% for transplanted patients and 50% for of immunosuppression, so decreasing post-transplant patients who remained on dialysis [6 ] . In a Spanish morbidity and mortality. Corticosteroids are mainly study the 1-year survival was better for dialysis responsible for cardiovascular and infectious complicapatients, but after 5 years the survival was 86% for tions after transplantation. Controlled trials showed transplant patients and 77% for dialysis patients [10] .
that cyclosporin monotherapy may permit a graft In an Italian study the 5-year survival for patients survival similar to that obtained with a triple-drug >55 years was 85% in transplanted patients vs 72% therapy even in younger adults [15] . In view of the for patients on dialysis [11] .
weaker immune response, steroid-free immunosuppresThus, in patients older than 55-60 years matched sion may therefore be recommended in the elderly. by age, diagnosis, and comorbid conditions, renal This may result in reduction of the risk of diabetes, transplantation may offer a better life expectancy than hypertension, hyperlipidaemia, osteoporosis, cataracts, dialysis, at 5 years. The difference could be even wider and other disturbing side-effects. Also the doses of if the early post-transplant mortality could be reduced.
calcineurin inhibitors may be reduced to prevent the potential nephrotoxicity of these drugs, which might
Practical recommendations
be of special concern with the increasing use of kidneys from older donors. These changes of immunosuppression may be carried out more safely today with the There is now sufficient evidence to conclude that older age per se does not represent a formal contraindication use anti-CD25 monoclonal antibodies [16 ] and mycophenolate mofetil [17] , that can reduce the risk of to renal transplantation. Nevertheless the current results could be further improved by decreasing the rejection.
The careful evaluation of the older candidate risk for death in older transplant recipients. Two main measures can be adopted to reduce mortality: (i) accu-coupled with a tailored immunosuppression may further improve the results of renal transplantation and rate selection and preparation of the recipient; (ii) immunosuppression tailored to the characteristics may allow further expansion of indications for kidney allografts in elderly people. of the older patient.
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